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Abstract 
Objective: Knee osteoarthritis (OA) is among the higher contributors to global 
disability. Despite its high prevalence, currently, there is no cure for this disease. 
Furthermore, the available diagnostic approaches have large precision errors and low 
sensitivity. Therefore, there is a need for new biomarkers to correctly identify early 
knee OA. 
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Study design and setting: We have created a machine learning based pipeline to 
identify small models (having few variables) that predict the 30-months incidence of 
knee OA (using multiple clinical and structural OA outcome measures) in overweight 
middle-aged women without knee OA at baseline. The data included clinical variables, 
food and pain questionnaires, biochemical markers and imaging-based information. 
Results: All the models showed high performance (AUC > 0.7) while using only a few 
variables. We identified both the importance of each variable within the models as well 
its direction. Finally, we compared the performance of two models with the state-of-
the-art approaches available in the literature. 
Conclusions: We showed the potential of applying machine learning to generate 
predictive models for the knee OA incidence. Imaging-based information were found 
particularly important in the proposed models. Furthermore, our analysis confirmed 
the relevance of known biochemical markers for knee OA.  Overall, we propose 5 
highly predictive small models that can be possibly adopted for an early prediction of 
knee OA. 
 
Keywords: knee osteoarthritis, machine learning, incidence, prediction  
 
 
1 Introduction 
Nowadays, knee OA is mainly diagnosed using clinical and radiographic 
changes generated by structural damages that occur late in the disease progression. 
In general, these techniques have a relatively large precision error and low sensitivity 
(1). Given the limitations of these imaging-based biomarkers (also known as “dry”), 
there is an increased need for identifying new and sensitive biochemical biomarkers 
(also called “wet”), other dry biomarkers (such as coming from MRI), or a combination 
of both that can detect early OA before structural damages and established clinical 
OA develop. Recently, several new approaches have been presented to tackle the 
lack of early knee OA detection (2).  The levels of serum COMP have been correlated 
with the development of knee OA (3), the incidence of clinical knee OA among middle-
aged overweight and obese women has been linked with the baseline fibulin-3 
concentrations (4) and it was shown to be negatively associated with the baseline 
concentration of COLL2-1NO2 (5). Finally, adipokines are suggested as predictive 
biomarkers for early onset post-traumatic knee OA (6). 
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Machine learning has already been used to elucidate the underlying biological 
processes related to OA (7–9). In the present study, we use a pipeline (a set of 
machine learning-based computational procedures) to analyse a cohort of women at 
high-risk for knee OA development with the aim of identifying novel biomarkers that 
can contribute to the early detection of knee OA. The core of this pipeline is 
represented by RGIFE (10), a machine learning based heuristic designed to generate 
small yet highly predictive models from complex biomedical data. Different than many 
presented works, we used 5 distinct outcome measures of incident knee OA to 
generate small predictive models (at most 8 variables) that provide high classification 
performance. Furthermore, we investigate the contribution and the direction of each 
variable within the predictive models. Finally, we contrast the performance of the 
proposed models with state-of-the-art approaches available in the specialised 
literature. Our method results effective in identify relevant factors that are related with 
knee OA incidence. More importantly, although focused on the analysis of data 
associated with knee OA, the proposed methodology is generic enough to be applied 
to a wide variety of biomedical data. It possesses the potential to discover and analyse 
the role of novel biomarkers for many different conditions and can help in understand 
their mechanisms. 
 
2 Method 
 
2.1 Dataset and individuals 
The data used in this work came from the PROOF study; a preventive randomised 
controlled trial including 407 middle-aged women with a BMI ≥27 kg/m2 free of clinical 
knee OA at baseline (11). After 30 months, the preventive effects of a diet & exercise 
program and of oral glucosamine sulphate were evaluated. Since no intervention 
effects were found, data were here treated as a cohort, with 5 different outcome 
measures of incident knee OA after 30 months: 
 
● incidence of ‘combined radiographic and clinical ACR-criteria’  
● incidence of frequent knee pain 
● lateral JSN of ≥ 1.0 mm  
● medial JSN of ≥ 1.0 mm  
● incidence of KL ≥ 2  
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Each individual was characterised by the value of 186 heterogeneous baseline 
variables (the full list of variables is available in the Supplementary Material). Data 
were derived from baseline questionnaires (including demographics, menopausal 
status, knee complaints, physical activity level, quality of life, habitual nutritional intake, 
and KOOS questionnaire), radiographs (for obtaining baseline KL grade, medial 
alignment angle, and knee joint shape using active shape modelling), MR images 
(scored with semi-quantitative MOAKS system (12) and used to define MRI OA (13)), 
physical examination (including pain upon palpation of knee structures, crepitus, 
presence of Heberden’s nodes, blood pressure, knee laxity and range of motion, 
warmth of the knee joint, waist circumference, and skinfolds for fat percentage 
calculation), and biochemical markers from serum and urine (fibulin3-1, fibulin3-2 and 
fibulin3-3 (4), COLL2-1NO2 (5), and C1M and C2M (14). A detailed description of the 
acquisition of non-biochemical variables is given elsewhere (11). Separate analysis 
was performed for the different definition of knee OA. From now onward we will refer 
to the 5 definitions, and the associated analysis, as: ACR criteria, Knee pain, Lateral 
JSN, Medial JSN and KL incidence. 
 
2.2 A machine learning pipeline for the generation of small predictive models 
 
2.2.1 The RGIFE heuristic 
The aim of this study was to identify biomarkers that can discriminate between 
incidence and non-incidence for 5 different outcomes measures of knee OA. RGIFE 
(Ranked Guided Iterative Feature Elimination) is a machine learning heuristic able to 
select few biomarkers with high predictive power (10). RGIFE is an iterative based 
heuristic, it discards features if their removal does not decrease the overall predictive 
performance of the computational model. By iteratively repeating the reduction 
process and performing other optimisation decisions, the method has been proven to 
select small sets of variables with high predictive power when analysing complex 
transcriptomics dataset (10). In fact, RGIFE has been designed to deal with 
challenging and difficult biomedical data, often characterised by a small number of 
samples that are likely to be defined in a high-dimensional space (that is described by 
thousands of variables). With specific optimisation techniques (e.g. oversampling, 
cost-sensitive learning, etc.), RGIFE can converge to reduced panels of biomarkers. 
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In our analysis, RGIFE used the random forest algorithm (15) to build the 
predictive models. A random forest consists of a collection of simple decision trees, 
where each of them is generated using a random (different) subsets of training 
samples and variables. The prediction for each individual is made based on the 
majority vote of the set of trees. That is, each sample is assigned to the class predicted 
by the majority of the decision trees. The PROOF data represented a difficult task from 
a machine learning point of view due to: 1) presence of many missing values and 2) 
imbalance distribution of the samples (much more non-incidence than incidence). The 
missing values were imputed using the K-means algorithm, while the imbalanced class 
distribution problem was tackled using the SPIDER oversampling method (16). For 
both methods we used the implementation in the KEEL machine learning package 
(17). 
 
2.2.2 Identification of the best model 
RGIFE is a flexible and fine tuneable algorithm, we used 30 different configurations to 
perform a full search in the space of all the optimal solutions (set of biomarkers) for 
each OA definition. The configurations differed in terms of maximum depth the random 
forest and misclassification costs (penalisation when misclassifying incidence samples 
during the learning phase).  
The best performing configuration was selected with a 10-fold cross-validation, 
a typical approach used in machine learning to evaluate the performance of a 
predictive. A n-fold cross-validation (in our analysis n=10) randomly divides the dataset 
into n equally-sized disjoint subsets (folds), each of them having the same distribution 
of positive and negative samples as in the complete dataset. In turn, each set is used 
as test set while the remaining n-1 are used as training set. By calculating the 
performance obtained using the test sets we can assess how the model will generalise 
to an independent dataset. In our analysis the 10-fold cross-validation was repeated 
10 times to minimise the bias introduced by the data being split into training and test 
set. Afterwards, using RGIFE on the complete dataset, we identified the best 
performing models (highest AUC calculated with a new 10 x 10-fold cross-validation) 
with at most 10 variables. The overall analytical process is presented in Figure 1. 
Because of this pipeline, in the results section, we will report two different AUC values, 
namely AUC-CV and AUC-Full. AUC-CV refers to the AUC obtained by the best 
performing configuration using a 10 x 10-fold cross-validation. AUC-Full, indicates the 
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performance, calculated using a new 10 x 10-fold cross-validation, of the best selected 
model generated when considering to the complete set of samples (with RGIFE using 
the best performing configuration). 
 Finally, we used a permutation test to assess how much better than random 
our models are. We contrasted the performance of 100 random models, generated 
from 100 permutated datasets (where the labels incidence and non-incidence) were 
randomly assigned) to the AUC obtained from the original data. An empirical p-value 
was estimated by counting the number of times in which a model provides better 
performance when trained with random data rather than the original data.  
 
 
 
Fig. 1 Analytic pipeline employed for the identification of the best predictive 
models. First, using a 10 x 10-fold cross-validation, the best performing configuration 
of RGIFE is identified. The predictive performance of the best configuration is indicated 
as AUC-CV. Then, using the selected set of parameters, RGIFE is applied 10 times 
(due to its stochastic behaviour) to the whole set of samples. Finally, the 10 generated 
models are ranked using the median AUC obtained with a new 10 x 10-fold cross-
validation. The top ranked model, whose performance is indicated as AUC-Full, is 
selected for the biomarker identification 
 
2.2.3 Model interpretation 
We analysed the role of the variables, within the models, by assessing both 
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their (additive) value and their association with the outcome (incidence of knee OA in 
this instance). The additive value was obtained from the generation of sub-models of 
decremental sizes, named decremental analysis. That is, from the original set of 
variables, we iteratively identified the one whose removal caused the smallest drop of 
AUC, hence contributing the less within the prediction task. The variable direction 
indicates how the value assumed by a variable, influences the presence of the disease 
(condition). This was accomplished by performing a partial dependence analysis, a 
method to visualise the partial relationship between the outcome and the predictive 
variables (18). The method evaluates the variations in predictions when the values of 
the variables are changed, thus it determines the relationship of the biomarkers with 
the outcome measure (see Section 2 of the Supplementary Material for a more 
detailed description).  
 
3 Results 
Out of all the subjects included in the PROOF study, 365 had follow-up data 
and were selected for the present study. The baseline characteristics of the individuals 
are presented in Table 1. A different total number of subjects was available for different 
knee OA outcome measures. The ACR criteria and chronic knee pain after 30 months 
occurred in 39 out 354 (11%) and in 51 out of 351 (15%) women respectively. The 
incidence of lateral JSN ≥ 1.0 mm was assessed in 41 (12%) out of 352 women, while 
medial JSN was seen in 38 (11%) women out of 352. Finally, the incidence of K&L ≥ 
2 was measured in 27 (8%) out of 321 individuals. A supplementary analysis was 
performed by using an outcome measure that combines 4 of the outcome measures: 
ACR criteria, K&L score, lateral and medial JSN. The aim was to check if a combined 
measure could help in generating better models. The results of this analysis are 
available in Section 3 of the Supplementary Material. 
 
Table 1  Baseline characteristics of the included subjects (N = 365) 
 Mean ± SD or percentage 
Age (yr) 55.7 ± 3.2 
BMI (kg/m^2) 32.3 ± 4.3 
Menopausal status 69% 
Western etnicity 96% 
Mild symptoms 45% 
Physical activity (SQUASH score) 6900 ± 3700 
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K&L = 1 60% 
K&L = 2 10% 
 
 
3.1 Best predictive models 
In Table 2, we report the models generated from the different OA definitions. The 
variables are grouped based on their source of information: OA measures (OA), 
clinical information (CI), Imaging-based data (IM), biochemical markers (BM), pain 
(PQ) and food questionnaire (FQ), all coming from the baseline assessments. Figure 
2 shows the ROC curves generated from each of the generated models.  
The best performing model was generated using the KL incidence OA outcome 
measure; it obtained an AUC-Full of 0.823 by using only 5 variables (smallest model). 
The second best performing model is associated with the ACR criteria and provided 
an AUC-Full of 0.788, however, it also contains the largest number of variables (8 in 
total). Finally, the JSN outcome measures led to the two lowest performance, 
respectively 0.731 for the lateral and 0.737 for the medial compartments. It is important 
to highlight how the rank of the models, created with different outcome measures, does 
not change while considering AUC-Full or AUC-CV.  
Table 2 shows that all the models incorporate variables of diverse categories, 
each one is defined by at least four different categories of variables. The imaging-
based variables are important for the ACR criteria model as well for JSN lateral. In 
particular, the Active Shape Models, statistical shape models constructed after placing 
75 landmark points along the contours of the tibia, fibula, femur and medial femoral 
condyle on each radiograph and using Principal Component Analysis to create 
independent modes of shape variation. More details are provided in (19,20). OA 
measures play a relevant role in the prediction of knee OA development when 
considering the chronic pain as outcome measure. Food information appears in almost 
every model (ACR criteria is the exception), most variables are related to the fruit 
intake per week, while the number of biscuits (sugar) consumed per week is used by 
the Knee pain model. Finally, we notice the presence of biochemical markers already 
associated, from the literature, with the incidence of knee OA such as the 
concentration of C1M, C2M (14) and COLL2-1NO2 (5). 
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Table 2 Summary of the best models for each knee OA outcome measure. 
Variables are baseline measures divided according to the type of information provided: 
OA information (OA), clinical information (CI), Imaging-based information (IM), pain 
questionnaire (PQ) and food questionnaire (FQ). The AUC column includes the AUC-
CV, the AUC-Full and the 95% Confidence Interval (Conf.Int.) of the AUC-Full. 
 
OA  
measure 
Biomarkers Cat. AUC-Full/ 
AUC-CV 
ACR 
criteria 
● KL grade ≥ 1 in one or both knees  
● Maximal isometric quadriceps strength  
● Mode 10, Mode 15, Mode 11 (Active Shape Modelling)       
● Presence of knee pain in the last month, Difficulties when kneeling 
● C2M concentration 
OA 
CI 
IM 
PQ 
BM 
0.788 / 0.692 
 
Conf.Int. 
0.712-0.863 
Knee pain ● KL grade ≥ 1 in one or both knees, KL grade ≥ 2 in one or both 
knees, WOMAC function score  
● Maximal isometric quadriceps strength  
● Mode 11 (Active Shape Modelling)       
● Difficulties when jumping 
● Frequency biscuits (raisins) /week 
OA 
 
CI 
IM 
PQ 
FQ 
0.755 / 0.637 
 
Conf.Int. 
0.680-0.830 
Lateral 
JSN 
● Fat percentage  
● Mode 1, Mode 10, Mode 11 (Active Shape Modelling) 
● Frequency of fruits / week 
● Concentration of Coll2-1NO2 adj. for creatinine 
CI 
IM 
FQ 
BM 
0.731 / 0.549 
 
Conf.Int. 
0.654-0.808 
Medial 
JSN  
● Quality of life, Nr. years since menopause, Waist circumference   
● Mode 15 (Active Shape Modelling) 
● Freq. bananas / week 
● C1M concentration 
CI 
IM 
FQ 
BM 
0.737 / 0.539 
 
Conf.Int. 
0.659-0.814 
KL 
incidence 
● BMI, HbA1c concentration 
● Presence of OA on MRI 
● Grinding / clicking sound when moving the knee 
● Frequency of apples and pears / week  
CI 
IM 
PQ 
FQ 
0.823 / 0.699 
 
Conf.Int. 
0.753-0.893 
 
 
All the performance were found statistically significant with a p-value < 0.0001. None 
of the models, when trained with randomised data, obtained higher AUC than what 
can be obtained from the original versions of the data (reported in Table 2).  
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Fig. 2 ROC curves of the presented modes. The ROC curves generated by the best 
performing models using five knee OA outcome measures. The AUC values refer to 
the AUC-Full 
 
3.2 Model interpretation 
The models generated from different knee OA outcome measures were interpreted in 
terms of both additive value and direction of their components (variables).  
 The additive value of each variable, within the predictive models, was assessed 
performing a decremental analysis. In Figure 3 we show the results of the analysis 
when using the Knee pain and KL incidence models (the only two models comparable 
with the literature findings) The full set of results, model by model, is available in 
Section 1 of the Supplementary Material. The y-axis of Figure 3 represents the AUC 
values of each submodel, while the variables defining the submodels are represented 
over each bar. In white the least important variables are highlighted, that is the 
variables that are not present in the following submodels. The KL scores (whether at 
baseline is ≥ 1 or ≥ 2) are the most valuable information in the Knee pain model, by 
themselves, the two variables get a good AUC of 0.663. From the KL incidence 
measure models we see that the two largest decreases in performance are associated 
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with the removal of the fruit intake per week and the knee grinding/clicking information. 
As for the Knee pain, the one variable model (presence of OA on MRI at baseline) can 
lead to an interesting AUC of 0.617. 
 
 
Fig. 3  Decremental models analysis. The decremental models generated using the 
Knee pain (left plot) and the KL incidence (right plot) measure for the knee OA 
definition. The variable highlighted in white represents the least, not present in the 
subsequent decremental model. 
  
 With the variable direction analysis, we determine if the change in intensity 
(value) of a variable corresponds to an increase of the probability to be affected by 
knee OA. That is, if a biomarker has a positive or a negative association with the OA 
outcome measure. Figure 4 shows the direction of two variables for the Knee pain and 
KL incidence models. Each data point corresponds to the average probability to belong 
to the positive (incidence) class. For binary variables (e.g. KL-grade ≥ 2) we report the 
distribution of the probabilities of the two possible values. As expected, a baseline KL 
grade ≥ 2 increases the probability for the knee OA incidence.  We also see that 
difficulties when jumping (high pain) might indicate higher chance develop the 
condition. Conversely, at the bottom plots of Figure 4, is illustrated a negative 
association between the frequency of apples and pears eaten per week and the knee 
OA outcome measure.  Finally, we observe how the analysis of MRI (at baseline) might 
provide insights about the development of knee OA in the individuals (overweight 
women in this instance) given its positive association.  
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Fig. 4  Variable direction analysis. The top plots show the direction of the “KL grade 
≥ 2” and “Difficulties when jumping” variables from the Knee pain model. The bottom 
plots illustrate the associations between the incidence of knee OA and the “Presence 
of OA on MRI” and “Frequency of apples and pears eaten per week” variables from 
the KL incidence model 
 
4 Discussions 
In this work, we developed 5 models that can be used to predict the incidence 
of knee OA in overweight and obese women. Differently than the traditional 
approaches, mostly based on the combination of univariate (where one variable at the 
time is analysed) and multivariate (where multiple variables are analysed together) 
logistic regression, we employed multivariate machine learning techniques. We 
showed that using a small subset of the available information (each model is defined 
by at most 8 variables) is possible to accurately predict the incidence of knee OA.  
We searched the specialised literature to identify models that can be compared with 
the predictive models generated using our machine learning approach. In Table 3 and 
4 we report a summary of the literature findings. We searched for models generated 
using data where the OA definition was similar to ours. Comparable models were 
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found only for the Knee pain and KL incidence outcome measures. For a fair 
comparison, we report, for each literature study, only the model AUC obtained using 
an internal validation (some studies also used external data to assess the 
performance). If multiple models (defined by different subset of variables) were 
available, we considered only the best performing. We want to highlight that these 
studies used a population that is different to the one associated with the PROOF study. 
Hence, the comparison of AUC values is just approximate. Nevertheless, such a 
comparison provides an idea if the presented models perform in line with the state-of-
the-art literature. All the models found in the literature were generated with the same 
statistical approach: a univariate analysis followed by a multivariate logistic regression 
method. In (21–23) the validation protocol, employed calculate the AUC values, is not 
described. Therefore, we assume, as common practice for clinical studies, that the 
published AUCs are equivalent to our AUC-Full values.  In (24) is mentioned that a 
“10-fold cross-validation strategy has been used as a feature selection strategy”, 
however, is not specified if the reported AUCs are associated with such strategy. Our 
internal validation indicated an AUC of 0.823 for the KL incidence model and an AUC 
of 0.755 for the Knee pain. 
 
Table 3 Summary of the KL incidence models identified in the specialised 
literature. JSW: Joint Space Width, B/L: baseline, F.U.: follow-up 
 
Reference AUC OA definition Attributes 
(21) 0.790 KL grade < 2 B/L and 
KL ≥  2 at F.U. 
Gender, age, BMI, knee pain and KL 
score at B/L 
(22) 0.690 KL grade < 2 B/L and 
KL ≥  2 at F.U. 
Gender, age, BMI, occupational 
risks, family osteoarthritis, previous 
knee injury  
(23) 0.740 KL grade < 2 B/L and 
KL ≥  2 at F.U. (5 
year) 
Gender, age, BMI, minimum JSW, 
osteophyte 
 
Table 4 Summary of the Knee pain models identified in the specialised literature. 
JSW: Joint Space Width, B/L: baseline, F.U.: follow-up 
 
Reference AUC OA definition Attributes 
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(23) 0.600 Painful knee at B/L; 
painful knee at F.U (4 
and 5 year) 
Age, pain intensity, minimum JSW, 
osteophyte 
(24) 0.623 Chronic right knee 
pain 
Osteophytes (OARSI grades 0–3) 
femur medial compartment, 
Chondrocalcinosis (grades 0-1) 
medial compartment (data taken 1 
year before the pain development) 
(24) 0.620 Chronic right knee 
pain 
Osteophytes (OARSI grades 0–3) 
femur medial compartment, 
Chondrocalcinosis (grades 0-1) 
medial compartment, Osteophytes 
(OARSI grades 0–3) femur lateral 
compartment (data taken 2 years 
before the pain development) 
 
 
Table 3 shows that our model for the prediction of KL incidence obtains higher 
performance than the models available in the literature while using the same or fewer 
variables. A superior performance also emerged when comparing the Knee pain 
model (see Table 4). However, differently than for the KL incidence, our Knee pain 
model is always larger (7 attributes) and more heterogeneous (imaging-based 
information, food and pain questionnaire data, OA and clinical information).  
 Within our modes, imaging-based variables contains valuable information for 
the risk for knee OA incidence. Every model of Table 2 contains a variable from the 
imaging category (IM). In addition, such an importance is confirmed by Figure 4, where 
is illustrated a positive association between the presence of OA on MRI at baseline 
and the incidence of knee OA (using KL grade). Overall, these results suggest a need 
in re-evaluating a proper use of imaging information in primary care settings, especially 
when treating subjects at risk for future knee OA development. However, it needs to 
be stressed that not all imaging-based variables included in the final models are easy 
to obtain in primary care; such as the outcomes of statistical shape modelling (‘Mode 
x’ variables). This warrants further attention. Furthermore, we hope that the relevant 
role of MRI features for the prediction of knee OA incidence in our model might direct 
the design of new studies that focus on early detection or early treatment of knee OA 
among a high-risk group of overweight and obese women. 
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The models generated with different knee OA outcome measures do not share 
many biomarkers. This is primarily due to the lack of overlap between “incident” 
individuals across different OA definitions. The Venn diagram included in Section 5 of 
the Supplementary Material illustrates this. There is no common agreement between 
all the measures for any single incident individual. The largest similarity occurs 
between ACR criteria and knee pain, the two measures that also generated the most 
analogous predictive models (this occurs because the ACR criteria can only be 
positive in presence of knee pain). However, this a low overlap might also be a signed 
that potentially different factors play a role in different aspects of the disease 
(radiographic onset, clinical onset, etc.), hence each panel of biomarkers exists of 
unique factors. A more tailored analysis in future work will be necessary to thoroughly 
characterise the potential link between models. 
 The proposed biomarkers can be grouped into two predictive categories: early 
signs (e.g. pain while jumping) as well as risk factors (e.g. BMI or waist circumference). 
The analysis performed for this manuscript used all the data collected by the PROOF 
study without discarding or filtering any of the available variables, this was to avoid 
any loss of relevant information. However, in future, we would like to apply the same 
approach by considering either only the early signs or the risk factors. Such an 
approach will give us the opportunity to propose different models that can be applied 
according to the information available for each possible individual been tested for the 
prediction of knee OA. 
  Several variables based on “wet” biomarkers of extracellular matrix tissue 
turnover also provided information on the risk of knee OA incidence. Both ACR criteria, 
medial and lateral JSN based prediction models all contained blood or urine-based 
biomarkers. C1M and C2M seemed to be negatively associated with the incidence OA 
defined by ACR criteria and medial JSN, in a similar way, COLL2-1NO2 showed a 
negative relationship with incidence OA defined by lateral JSN. Previous studies have 
found correlations between OA severity and C1M (14) and a difference in C2M levels 
between OA and healthy subjects (25). Furthermore, the negative association 
between COLL2-1NO2 and OA incidence is in line with a previous study also 
performed using the PROOF cohort (5) with a different analytical approach (binary 
logistic regression), thus providing some degree of confirmation of both the relevance 
of the biochemical marker and the goodness of our methodology. These findings 
suggest that assessment of structural degradation products from the extracellular 
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matrix in body fluids may provide valuable information on the development OA and 
prediction of disease incidence in high-risk groups.   
The presented models perform quite well in the discrimination of incidence and 
non-incidence knee OA among overweight and obese women. Their performance can 
be considered as “fair” (AUCs is between 0.70 - 0.80) and “good” (AUCs between 
0.80-0.90). However, it will be necessary to evaluate the predictive power of each 
model using an independent set of individuals (external validation). Given that it will 
be extremely unlikely to obtain new validation data that will include all the variables 
employed by our models, the role of the decremental analysis will be fundamental. 
Based on the variables available in the new data, the performance of the best fitting 
submodel will be easily extracted from the decremental analysis, illustrated as in 
Figure 3, and compared with the AUCs obtained from the new external samples. 
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